On May 19th, in the vibrant summer sunshine, the "2023 Shanghai G60 Medical New Economy Forum and Dunwill Medical Headquarters Completion Ceremony" was grandly held, hosted by Dunwill Medical and guided by Shanghai Songjiang District Economic Committee and Shanghai Lingang Songjiang Science and Technology City. Ms. Sofia Wen, CEO and founder of Dunwill Medical, along with the company's senior management, employees, partners, and distributors participated the event. Nearly 400 representatives and relevant government leaders from Songjiang District, Shanghai, gathered together to witness this milestone moment.

More than 30 distinguished guests including Jia Shunjun, Mayor of Jiuting Town, Songjiang District, Shanghai; Xu Hao, Deputy Director of the Economic Commission of Songjiang District, Shanghai; Hu Zhihua, Head of the Technical Progress Department of the Economic Commission of Songjiang District, Shanghai; Yang Lingyu, General Manager of Shanghai Lingang United Development Co., Ltd.; Xue Youtian, Deputy General Manager of Shanghai Lingang United Development Co., Ltd.; Du Lin, Partner of Huaxin Capital under Luxin Venture Capital; Liu Yimin, Managing Director of Tongchuang Weiye, Zhang Jun, Joint Director and General Manager of the Medical and Health Group of CITIC Securities Investment Bank, He Pengzhi, Senior Director of Roche Diagnostics, Fan Jia, Dean of Zhongshan Hospital affiliated to Fudan University, Shen Feng, Dean of Clinical Research Institute of Shanghai Oriental Hepatobiliary Surgery Hospital, Zhou Jian, Vice Dean of Zhongshan Hospital affiliated to Fudan University, Song Zhenju, Director of Science and Education Department of Zhongshan Hospital affiliated to Fudan University, and Hou Yingyong, Director of Pathology Department of Zhongshan Hospital affiliated to Fudan University including Sun Zhan, Vice President of Shanghai Geriatrics Center, attended the event.

A thousand-mile trip begins with one step. A hundred Zhang high platform starts from a fortress. Jia Shunjun, the mayor of Jiuting Town, Songjiang District, Shanghai, delivered an opening speech for the ceremony: "In recent years, Songjiang Economic and Technological Development Zone has seized the opportunities for the development of the biopharmaceutical industry. The zone has already covered biopharmaceutical enterprises in fields such as biopharmaceuticals, medical devices, and health industries, forming a development trend that covers the entire industry chain upstream and downstream. Under the background of Songjiang District, Dunwill Medical will surely accelerate its high-quality development and achieve more cutting-edge technology research and core technology breakthroughs in the future."

Jia Shunjun, Mayor of Jiuting Town, Songjiang District, Shanghai

Xu Hao, Deputy Director of the Shanghai Songjiang District Economic Committee, warmly welcomed the hosting and guests of this event. Dunwill Medical is highly aligned with the industrial orientation of Songjiang District, and the biopharmaceutical industry will undoubtedly gain wings and add high momentum to the high-quality development of the industry.

Xu Hao, Deputy Director of Shanghai Songjiang District Economic Committee

Xue Youtian, Vice General Manager of Shanghai Lingang United Development Co., Ltd., extended his sincerest wishes to Dunwill Medical Headquarters for the completion of its headquarter in Lingang Songjiang Science and Technology City. The biopharmaceutical industry is one of the key leading industries in Songjiang District. As a demonstration base for the transfer and transformation of scientific and technological achievements in the G60 Science and Technology Innovation Corridor in the Yangtze River Delta, Lingang Songjiang Science and Technology City fully leverages the platform role of Lingang Park and Songjiang District, Under the cooperation of all parties, we will continue to promote the high-quality development of the science and technology innovation industry in Songjiang District.

Xue Youtian, Deputy General Manager of Shanghai Lingang United Development Co., Ltd

Medical and health care has always been a key focus of Luxin Venture Capital. Du Lin, General Manager of Huaxin Venture Capital, said, "Dunwill Medical has an experienced multidisciplinary research and development team and a multi omics analysis platform. It is a very rare enterprise in the industry that has all the capabilities from basic research to product transformation to commercialization. We believe that in the future, Dunwill Medical will develop rapidly and become a unique pharmaceutical company in China's IVD field."

Du Lin, Managing Director of Luxin Venture Capital and General Manager of Huaxin Venture Capital

Finally, Ms. Sofia Wen, CEO and founder of Dunwill Medical, warmly welcomed all the guests and expressed sincere gratitude to the government agencies, association organizations, company employees, upstream suppliers, and customer partners who have supported Dunwill's continuous development along the way. She also strengthened Dunwill's determination to create new glory and strive to become a world-leading company focused on the discovery, development, and commercialization of innovative original biomarker. In the past 17 years, Dunwill has accumulated valuable experience in clinical cooperation and innovation transformation with top hospitals in China. On the path of medical innovation, we will always respect science, respect life, face competition and challenges in the company's development process calmly, and continuously develop more original products under the "medicine-research-production" ecosystem to serve Chinese patients and doctors!

Ms. Sofia Wen, CEO and founder of Dunwill Medical

After the wonderful speeches of multiple guests, the ribbon cutting ceremony was held. The ceremony was attended by the Managing Director of Luxin Venture Capital, Du Lin, General Manager of Huaxin Venture Capital, Yang Lingyu, General Manager of Shanghai Lingang United Development Co., Ltd., Xue Xitian, Deputy General Manager of Shanghai Lingang United Development Co., Ltd., Ms. Sofia Wen, CEO and founder of Dunwill Medical, Liu Zhanjie, General Manager of Jusbio Sciences, and Mark Zhou, CFO of Dunwill. Guests on site celebrated the official opening of Dunwill headquarters with warm applause and took a group photo together.

After the ribbon cutting ceremony, under the guidance of the tour guide, the leaders and guests visited the new headquarters building. The tour guide shared Dunwill's experiences and stories in technology research and development, management, and innovation. The leaders and guests highly praised and Dunhui's technical level, management ability, and future development plans. We believe this will motivate Dunwill to continuously improve in future development, keep to be innovative and have good spirit.

The completion of the headquarters is a new beginning for Dunwill to establish itself in a new stage of development and embark on a new journey. It is an important sign for all Dunwill employees to continuously strive for progress and climb the ladder, and it is also a new starting line for Dunwill to continue its success. Dunwill Medical will emerge from the new, ready to take action, stick to innovation, and grow fearlessly!